In This Article:
Fresenius SE KGaA (ETR:FRE) First Quarter 2025 Results
Key Financial Results
-
Revenue: €5.65b (up 5.6% from 1Q 2024).
-
Net income: €456.0m (up 51% from 1Q 2024).
-
Profit margin: 8.1% (up from 5.7% in 1Q 2024). The increase in margin was driven by higher revenue.
-
EPS: €0.81 (up from €0.54 in 1Q 2024).
We've discovered 2 warning signs about Fresenius SE KGaA. View them for free.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Fresenius SE KGaA Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 3.9%. Earnings per share (EPS) missed analyst estimates by 35%.
Looking ahead, revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Healthcare industry in Germany.
Performance of the German Healthcare industry.
The company's shares are up 2.3% from a week ago.
Risk Analysis
You should learn about the 2 warning signs we've spotted with Fresenius SE KGaA.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.